ClinicalTrials.Veeva

Menu
H

Homestead Associates In Research | Homestead, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SAR441566
MK-6024
SEL-212
Semaglutide
Teriflunomide
RO7790121
Apalutamide
Remibrutinib
MTX
Inebilizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 26 total trials
Locations recently updated

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatit...

Enrolling
Metabolic Dysfunction-associated Steatotic Liver Disease
Non-alcoholic Fatty Liver Disease
Combination Product: Efinopegdutide
Combination Product: Placebo

The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythemat...

Enrolling
Active Refractory Rheumatoid Arthritis
Systemic Lupus Erythematosus
Drug: Blinatumomab
Drug: Inebilizumab

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-...

Enrolling
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.

Active, not recruiting
Crohn's Disease
Biological: JNJ-78934804
Biological: Golimumab

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) co...

Enrolling
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo
Locations recently updated

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with mod...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

This study will evaluate the safety and efficacy of empasiprubart compared with placebo in adult participants with dermatomyositis (DM).The study dur...

Enrolling
Myositis
Dermatomyositis
Other: Placebo IV
Biological: Empasiprubart IV

Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakizumab in subjects with moderate to severe genital psoriasis.

Enrolling
Moderate to Severe Genital Psoriasis
Drug: Tildrakizumab 100 mg
Drug: Placebo

This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o...

Enrolling
Crohn's Disease
Drug: SAR441566
Drug: SAR441566 matching Placebo

The protocol of this Phase 2 clinical trial consists of a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficac...

Enrolling
Colitis Ulcerative
Drug: Placebo
Drug: Dupilumab

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus peglot...

Active, not recruiting
Gout
Drug: Methotrexate
Biological: Pegloticase

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

Trial sponsors

Amgen logo
Janssen (J&J Innovative Medicine) logo
G
Merck Sharp & Dohme (MSD) logo
Sanofi logo
Boehringer Ingelheim logo
C
Karuna Therapeutics logo
M
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems